Showing results (171-180 of 317) with videos related to
Sort By:
Pageof 32
JCO Global Oncology|October 16, 2020
Outcomes for Step-Wise Implementation of a Human Papillomavirus Testing-Based Cervical Screen-and-Treat Program in El SalvadorKarla Alfaro, Mauricio Maza, Juan C Felix, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2020
Effect of Dexrazoxane on Left Ventricular Systolic Function and Treatment Outcomes in Patients With Acute Myeloid Leukemia: A Report From the Children's Oncology GroupKelly D Getz, Lillian Sung, Todd A Alonzo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2015
Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology GroupKatherine Tarlock, Todd A Alonzo, Robert B Gerbing, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2024
DNA Damage Response Pharmacogenomic (DDR_PGx) Score Predicts Response to Chemotherapy Consisting of Gemtuzumab Ozogamicin in Pediatric AML: A Report from the Children's Oncology GroupVivek M Shastri, Lata Chauhan, Mohammed Gbadamosi, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2019
A Phase 2 Trial of KIR-Mismatched Unrelated Donor Transplantation Using in Vivo T Cell Depletion with Antithymocyte Globulin in Acute Myelogenous Leukemia: Children's Oncology Group AAML05P1 StudyStella M Davies, Robert Iannone, Todd A Alonzo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951Robert J Wells, Mary T Adams, Todd A Alonzo, et al.Blood|September 10, 2005
XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia: a Children's Oncology Group reportParinda A Mehta, Todd A Alonzo, Robert B Gerbing, et al.Blood|June 1, 2012
Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology GroupMichael R Loken, Todd A Alonzo, Laura Pardo, et al.Psychosomatic Medicine|March 25, 2004
Gender differences in quality of life among cardiac patientsCharles F Emery, David J Frid, Tilmer O Engebretson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2021
CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology GroupAdam J Lamble, Lisa Eidenschink Brodersen, Todd A Alonzo, et al.Pageof 32